Skip to main content
. 2019 Nov 21;63(12):e01427-19. doi: 10.1128/AAC.01427-19

TABLE 1.

Basic characteristics and clinical data for infected HD patients who received ertapenem treatment during hospitalization (n = 22)a

Characteristicb Reference groupc (n = 11) Experimental groupd (n = 11) P
Age (yr) 63.2 ± 16.6 66.4 ± 16.1 0.653
No. male/no. female 4/7 4/7 0.67
Body height (cm) 159.7 ± 10.8 159.1 ± 10.7 0.906
Body weight (kg) 60.3 ± 14.1 62.0 ± 17.4 0.804
Total body fluid removal (liters) 1.4 ± 1.3 1.7 ± 1.1 0.602
Systolic BP (mm Hg) 136.0 ± 25.2 140.8 ± 23.7 0.649
Diastolic BP (mm Hg) 79.7 ± 17.8 80.8 ± 12.0 0.868
Blood flow in HD (ml/min) 201.8 ± 41.4 210.5 ± 26.5 0.567
Dialysate flow in HD (ml/min) 500 500 1
Kt/V 1.6 ± 0.2 1.4 ± 0.4 0.108
URR (%) 73.5 ± 5.0 69.3 ± 9.3 0.209
Albumin level (g/dl) 3.3 ± 0.3 3.2 ± 0.6 0.934
BUN level (mg/dl) 63.7 ± 17.9 80.7 ± 23.1 0.068
Cr level (mg/dl) 8.2 ± 2.6 8.3 ± 1.7 0.929
a

All patients were local HD patients in Taiwan.

b

Kt/V, dialysis efficiency; URR, urea reduction rate; BUN, blood urea nitrogen; Cr, creatinine. Continuous variables are shown as mean ± standard deviation. The normal range for albumin levels is 3.5 to 5.7 mg/dl, that for blood urea nitrogen levels is 7 to 25 mg/dl, and that for creatinine levels is 0.6 to 1.3 mg/dl.

c

In the reference group, HD patients received ertapenem at 500 mg daily.

d

In the experimental group, HD patients received ertapenem at 500 mg thrice weekly, after each HD session.